Skip to main content
. 2021 Mar 11;12:634832. doi: 10.3389/fimmu.2021.634832

Table 2.

Descriptive statistics for all the proteins assessed.

A B C D E
Protein Time 1 (pg/mL) Time 2 (pg/mL) Wilcoxon Signed Ranked Test p-values
Median IQR Median IQR Overall LVLVs IVLVs HVLVs
GM-CSF 0.247 0.154 0.252 0.148 0.629 0.432 0.61 0.695
IL-1α 0.318 0.961 0.13 0.499 0.162 0.236 0.624 0.722
IL-5 0.755 1.022 0.767 0.886 0.339 0.77 0.492 0.193
IL-7 1.279 0.573 1.306 1.016 0.792 0.695 0.695 0.922
IL-12/IL-23p40 84.18 86.74 72.94 61.74 0.164 0.432 1 0.084
IL-15 1.494 1.914 1.355 2.045 0.502 0.919 0.636 0.407
IL-16 216.6 118.9 205.1 148.5 0.641 0.846 0.625 0.232
TNF 0.164 0.102 0.159 0.08 0.175 0.103 0.922 0.492
IFN-γ 5.577 5.834 6.08 3.984 0.245 0.695 0.77 0.01
IL-1β 0.112 0.06 0.119 0.053 0.764 0.141 1 0.636
IL-2 0.403 0.356 0.303 0.307 0.202 0.695 0.636 0.16
IL-4 0.041 0.035 0.043 0.062 0.665 0.492 0.193 0.636
IL-6 0.851 0.701 1.074 0.83 0.245 0.037 0.232 0.131
IL-10 0.992 1.409 0.706 0.808 0.012 0.064 0.492 0.084
IL-12p70 0.143 0.291 0.169 0.245 0.863 0.432 0.922 0.407
IL-13 0.69 4.281 0.974 2.534 0.903 0.557 0.846 0.625
IL-1Rα 106.6 97.5 96.12 89.15 0.262 0.492 0.922 0.131
IL-17A 3.058 2.193 2.802 1.457 0.171 0.557 0.625 0.084
IL-17AF 2.043 2.281 2.143 1.428 0.968 0.77 0.77 0.625
IL-17B 0.952 0.684 1.058 0.894 0.428 1 1 0.084
IL-17C 3.065 4.577 1.943 4.364 0.07 0.006 0.557 0.922
IL-17D 14.68 10.25 13.69 9.831 0.761 0.625 0.557 0.625
Eotaxin 99.99 37.99 91.61 67.6 0.584 1 0.846 0.322
MIP-1β 24.13 13.78 25.5 20.39 0.871 0.922 0.695 0.846
Eotaxin3 14.73 11.03 13.9 12.95 0.67 0.846 0.625 0.557
TARC 42.4 36.19 39.67 37.17 0.109 0.432 0.432 0.375
IP-10 264.3 265.9 258.3 211 0.984 0.625 0.131 0.193
MIP-1α 9.032 4.086 8.558 4.78 0.655 0.232 0.77 1
IL-8 138.8 102.5 108.4 106.3 0.99 1 0.722 0.922
MCP-1 80.6 29.55 76.76 35.29 0.516 0.492 0.846 0.77
MDC 666.7 263.8 711.3 434.7 0.245 0.492 0.625 0.695
MCP-4 17.2 9.422 17.08 10.46 0.371 0.131 0.77 0.625
MIP-3α 7.554 4.884 5.984 4.640
VEGF 11.01 6.808 10.61 5.739 0.67 1 0.77 0.922
VEGFC 7.471 13.21 10.14 18.31 0.221 0.695 0.625 0.322
VEGFD 154.6 204.5 127.7 196.1 0.328 0.77 0.846 0.492
Tie2 2636 3500 2644 4066 0.777 0.232 0.625 0.922
Flt-1 16.54 36.8 19.7 31.68 0.503 0.846 0.922 0.275
PIGF 0.585 2.367 0.734 2.384 0.73 0.625 0.492 0.846
βFGF 0.592 1.014 0.67 1.435 0.213 0.432 0.232 1
SAA 1219000 2977000 1384000 13780000 0.135 0.375 0.027 0.492
CRP 1029000 3681000 1455000 6862000 0.158 0.432 0.027 0.432
VCAM1 658600 334200 617900 168700 0.02 0.492 0.16 0.16
ICAM1 518300 287700 551800 258800 0.839 0.922 0.695 1
IL-3 6.858 7.636 6.777 6.496 0.57 0.432 0.322 0.432
IL-9 0.502 0.415 0.476 0.299 0.213 0.922 0.432 0.193
TSLP 0.75 0.488 0.706 0.413 0.158 0.064 0.432 0.695
IL-21 1.723 2.404 0.872 1.828 0.08 0.286 0.183 0.636
IL-31 0.117 0.123 0.088 0.104 0.114 0.131 0.322 1
IL-27 1425 431.2 1554 677 0.855 1 0.557 0.232
IL-23 0.359 8.859 0.359 3.284 0.74 0.813 0.371 1
IL-22 1.61 5.837 2.356 6.818 0.641 0.322 0.625 0.492

(A): Median and IQR shown at each timepoint for all 30 volunteers. (B–E): The null hypothesis of the difference between the two time points assessed was assessed using Wilcoxon Signed Ranks tests for all volunteers (B), LVLVs (C), HVLVs (D) and HVLVs (E). p-values below 0.05 were interpreted to be significant. Proteins are presented by broad functional groups. Bold values indicate where p values are less than 0.05.